Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human iPSC-based drug testing platform for muscular dystrophy

Human iPSC-based drug testing platform for muscular dystrophy

US Patent 12169196 · Granted Dec 17, 2024

Estimated economic value: $67,189,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Optically controllable FGFR stimulation using wireless controlled cellular light2025
AAV capsids identified by in vivo library selection2024
AAV capsids identified by in vivo library selection2022
Isolation of fusion-competent myoblasts and therapeutic applications thereof rel2022
Isolation of fusion-competent myoblasts and therapeutic applications thereof rel2022